Khondrion B.V.
- Address
- Transistorweg 5
Sponsor Overview
Specializations
Primary mitochondrial disease
Khondrion B.V. is focused on mitochondrial medicine, with research centred on primary mitochondrial disease and the clinical burden associated with the m.3243A>G mitochondrial DNA variant.
- Mitochondrial DNA 3243A>G-related disease
- MIDD and MELAS
- Multi-system mitochondrial phenotypes
The sponsor’s clinical activity is directed toward conditions marked by energy metabolism impairment and broad multi-organ involvement.
Neuromuscular and functional impairment
Its research landscape includes symptoms and complications affecting skeletal muscle function, physical fatigue, and day-to-day mobility in people with mitochondrial disorders.
- Lower limb muscle weakness
- Dynamic balance control
- Physical fatigue and activity limitation
These areas reflect interest in functional outcomes that influence independence and quality of life.
Quality of life and symptom burden
Khondrion B.V. also places emphasis on patient-facing outcomes associated with chronic mitochondrial disorders, including the impact of symptoms on daily living and health-related quality of life.
- Fatigue-related disability
- Mobility and functional capacity
- Patient-reported symptom impact
Its clinical interest extends to measuring how mitochondrial disease affects practical functioning in everyday settings.
Therapeutic development in mitochondrial disorders
The company’s research activity is aligned with pharmaceutical development for inherited mitochondrial conditions, with a therapeutic focus on clinical manifestations that are difficult to manage in routine care.
- Mitochondrial dysfunction
- Multisystem disease manifestations
- Symptom-directed mitochondrial therapy
This includes attention to disorders involving both neurological and muscular involvement.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| A Phase III, randomised, double-blind, placebo-controlled, parallel-group, pivotal trial to assess the efficacy and safety of sonlicromanol in adult subjects with a genetically confirmed mitochondrial DNA tRNALeu(UUR) m.3243A>G variant. |  Denmark France Germany Italy The Netherlands | Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 6 sites across their trial portfolio.
Therapeutic Focus
- 1.Nervous System Diseases1 trial449 other sponsors
Partnered Research Centres
6 centres- Address
- 1 Rue Jean Burguet, 33000 Bordeaux
- Address
- Via Giacomo Venezian 1, 20133 Milan
- Address
- 100 Boulevard Du General Leclerc, 92110 Clichy
- Address
- Pettenkoferstrasse 8a, Ludwigsvorstadt-Isarvorstadt, 80336 Munich
- Address
- Blegdamsvej 9, 2100 Copenhagen
- Address
- Geert Grooteplein Noord 9, 6525 EZ Nijmegen
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Khondrion B.V..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.